Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
GlobeNewswire
Topline results of the Phase 1b/2a clinical trial anticipated mid-year 2024
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) --..